Cerebral Vasoreactivity in HeartMate 3 Patients
Stöhr, Eric J.
Cockcroft, John R.
Wedi’i wahardd nes
MetadataDangos cofnod eitem llawn
BACKGROUND: While rates of stroke have declined with the HeartMate3 (HM3) continuous flow (CF) left ventricular assist device (LVAD), the impact of non-pulsatile flow and artificial pulse physiology on cerebrovascular function is not known. We hypothesized that improved hemodynamics and artificial pulse physiology of HM3 patients would augment cerebrovascular metabolic reactivity (CVR) compared with HeartMate II (HMII) CF-LVAD and heart failure (HF) patients. METHODS: Mean, peak systolic and diastolic flow velocities (MFV, PSV, MinFV, respectively) and cerebral pulsatility index (CPI) were determined in the middle cerebral artery (MCA) before and after a 30s breath-hold challenge in 90 participants : 24 healthy controls; 30 HF, 15 HMII, and 21 HM3 patients. RESULTS: In HM3 patients, breath-holding increased MFV (Δ8±10 cm/s, P<0.0001 vs. baseline) to levels similar to HF patients (Δ9±8 cm/s, P>0.05), higher than HMII patients (Δ2±8 cm/s, P<0.01) but lower than healthy controls (Δ13±7 cm/s, P<0.05). CF-LVAD altered the proportion of systolic and diastolic flow responses as reflected by a differential CPI (P=0.03). Baseline MFV was not related to CVR (r2=0.0008, P=0.81). However, CF-LVAD pump speed was strongly inversely associated with CVR in HM II (r2=0.51, P=0.003) but not HM3 patients (r2=0.01, P=0.65). CONCLUSIONS: Compared with HMII, HM3 patients have a significantly improved CVR. However, CVR remains lower in HM3 and HF patients than in healthy controls, therefore suggesting that changes in cerebral hemodynamics are not reversed by CF-LVAD therapy. Further research on the mechanisms and the long-term impact of altered cerebral hemodynamics in this unique patient population are warranted.
Journal of Heart and Lung Transplantation;
Stöhr, E.J., Ji, R., Akiyama, K., Mondellini, G., Braghieri, L., Pinsino, A., Cockcroft, J.R., Yuzefpolskaya, M., Amlani, A., Topkara, V.K. and Takayama, H., Naka, Y., Uriel, N., Takeda, K., Colombo, P., McDonnell, B. & Willey, J. (2021) 'Cerebral Vasoreactivity in HeartMate 3 Patients', The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2021.05.005
Dynodwr Gwrthrych Digidol (DOI)https://doi.org/10.1016/j.healun.2021.05.005
Article published in Journal of Heart and Lung Transplantation available at https://doi.org/10.1016/j.healun.2021.05.005
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 705219, and from the Lisa and Mark Schwartz Program to Reverse Heart Failure at New York – Presbyterian Hospital/Columbia University.
- Sport Research Groups 
Yn dangos eitemau sy’n perthyn drwy deitl, awdur, pwnc a chrynodeb.
Oxygen therapy improves cerebral oxygen delivery and neurovascular function in hypoxaemic chronic obstructive pulmonary disease patients Hoiland, Ryan; Mladinov, S.; Barak, O.; Willie, C.; Mijacika, T.; Stembridge, Mike; Dujic, Z.; Ainslie, Philip N. (Wiley, 2018-07-05)How does oxygen therapy influence cerebral blood flow, cerebral oxygen delivery and neurovascular function in chronic obstructive pulmonary disease patients? Oxygen therapy improves cerebral oxygen delivery and neurovascular ...
Stöhr, Eric J.; McDonnell, Barry (2018-10-01)For the first time in history, some humans live without a palpable pulse (Purohitet al., 2018). This 65remarkable physiology is the consequence of surgical implantation of a continuous-flow left 66ventricular assist ...
CrossTalk proposal: Blood flow pulsatility in left ventricular assist device patients is essential to maintain normal brain physiology Stöhr, Eric J.; McDonnell, Barry; Colombo, Paolo; Willey, Joshua Z. (The Physiological Society, 2018-12-17)For the first time in history, some humans live without a palpable pulse (Purohit et al. 2018). This remarkable physiology is the consequence of surgical implantation of a continuous‐flow left ventricular assist device ...